Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

CAMBRIDGE, Mass., Jan. 15, 2014 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced initial results from its Phase 2a study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome (PWS), a severe form of genetic obesity.  These results showed improvements in body weight, hunger-related behaviors, and body composition, including reductions in body fat content and preserved lean body mass following four weeks of treatment. 

These changes were observed despite the increased caloric intake that was a component of this trial.  Known markers of beloranib response including those associated with cardiovascular disease risk were also improved, demonstrating that PWS patients responded to the molecular mechanism of beloranib.

"The results of this short-term proof-of-concept study are very promising and underscore our belief that beloranib has the potential to successfully treat this severe form of obesity.  To our knowledge, this study represents the largest placebo-controlled, randomized, multiple dose trial to date for obesity in this patient population, and these results bode well for further study of beloranib in patients with this devastating condition," said Thomas Hughes, Ph.D., President and Chief Executive Officer of Zafgen.

Similar to results seen in non-PWS obese patient populations, beloranib treatment in this study reduced body fat content by 8.1% vs. placebo in four weeks of treatment at the highest study dose of 1.8 mg, despite a 50% increased daily caloric allowance.  Hunger-related behaviors improved, and a trend towards overall improvement in body weight was seen, although this did not reach statistical significance, in part due to the fact that study was not powered to demonstrate these differ
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Today, Rhodes Pharmaceuticals ... system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity ... Summer 2015. The announcement comes ... from the U.S. Food and Drug Administration (FDA). ... formulation of methylphenidate capsule with an onset of ...
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain ... a leading retail drugstore chain in China ... stores, today announced the resignation of Mr. Fuxiang ... personal reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... the Company,s board of directors, effective immediately. Meanwhile, Ms. ...
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... , ATLANTA, Dec. 16 Medlytix, a national healthcare ... half-billion dollar milestone - the total amount of money that ... than a half-million patients nationwide by doing a better job ... years. , "We,re proud that each of these hospitals enhanced ...
... , SOMERVILLE, N.J., Dec. 16 Ethicon, Inc., a ... a worldwide leader in surgical care, and Acclarent, Inc., a ... commercializing devices that address conditions affecting the ear, nose and ... will acquire Acclarent in an all-cash transaction for approximately $785 ...
Cached Medicine Technology:Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4
(Date:5/22/2015)... River Valley Health Partners (RVHP) Board ... system’s Chief Financial Officer (CFO), will be leaving the ... the company CFO since 2011. , The Board of ... health system as CFO. Wesley will oversee the health ... Board of Trustees conducts a formal search for a ...
(Date:5/22/2015)... 2015 Combination therapy, or polytherapy, ... chronic obstructive pulmonary disorder (COPD) as the dominant ... plc as well as Germany’s Boehringer Ingelheim compete ... But will market payers, clinicians and patients be ... to completely new ones? , In spite of ...
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
(Date:5/22/2015)... 2015 The dentist in ... that they are now offering complimentary consultations to ... treatments. At consultations, patients can discuss their candidacy ... certain treatments can achieve and whether alternative options ... initial appointment. If treatments are chosen, patients can ...
Breaking Medicine News(10 mins):Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2
... one of the large states of India accounts for 1.5 ... ,The government of Andhra Pradesh is set to make it ... This is done with a motive of putting an end ... ,"Since condom use is not very popular, we are ...
... States and Europe are registering men with advanced prostate ... chemotherapy with high-dose of Calcitriol, a naturally occurring active ... will test whether specially formulated high-dose vitamin D, taken ... increase survival time and improve quality of life in ...
... New research shows that unbelted backseat passengers risk injury or ... them in the event of a head-on crash.// ... using crash-test dummies have demonstrated the likelihood of severe head ... unbelted passenger slamming into the seat of a belted driver. ...
... the private educational institutions in the state in a ... decided to adopt the new rules for the betterment ... here. ,The school managements will now be ... and timely salaries to teaching and non-teaching staff and ...
... of many a party. That apart, wine is very much in ... to sustain cardiovascular// health and keep age related dementia at bay. ... to a copious flow of health benefits. ,The roots ... alluding to the blood of Christ, which the Christians believe, is ...
... of North Carolina at Chapel Hill suggested that low ... ,LDL stands for low density lipoprotein; the ... status. Previously associations have been made between LDL and ... with Parkinson's disease have a lower occurrence of heart ...
Cached Medicine News:Health News:Unbelted Backseat Passengers Produce Deadly Results 2Health News:Celebrating Christmas With Wine – The Elixir of the God 2Health News:Celebrating Christmas With Wine – The Elixir of the God 3Health News:Low LDL Levels Lead to Parkinson's Disease 2
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: